Literature DB >> 1958220

Osteoclast resorption-stimulating activity is associated with the osteoblast cell surface and/or the extracellular matrix.

K Fuller1, A C Gallagher, T J Chambers.   

Abstract

Osteoblasts mediate much of the hormonal responsiveness of osteoclasts. We and others have found that one mechanism through which this regulation is effected is by release of osteoclast resorption-stimulating activity (ORSA) into culture supernatants. However, although hormonal responsiveness is regularly observed in co-cultures, ORSA is not always detectable in conditioned media. We show here that one explanation for this finding is that ORSA may be retained by heparin-like glycosaminoglycans (GAGs) of the cell surface or extracellular matrix of osteoblasts. We found that protease-sensitive ORSA could be extracted from monolayers of the osteoblastic cell line UMR 106 with 2M NaCl or collagenase. Production of this activity was increased in response to 1,25(OH)2D3. The presence of the GAG heparin was required to reveal ORSA. Immobilisation of ORSA by GAGs may assist osteoblastic cells in the regulation of the complex patterns of osteoclastic activity observed during skeletal morphogenesis and restructuring.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958220     DOI: 10.1016/s0006-291x(05)81382-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Functional and structural interactions between osteoblastic and preosteoclastic cells in vitro.

Authors:  S Z Orlandini; L Formigli; S Benvenuti; L Lasagni; A Franchi; L Masi; P A Bernabei; V Santini; M L Brandi
Journal:  Cell Tissue Res       Date:  1995-07       Impact factor: 5.249

2.  Chondroclasts are mature osteoclasts which are capable of cartilage matrix resorption.

Authors:  H J Knowles; L Moskovsky; M S Thompson; J Grunhen; X Cheng; T G Kashima; N A Athanasou
Journal:  Virchows Arch       Date:  2012-07-11       Impact factor: 4.064

3.  Fuzzy clustering analysis of osteosarcoma related genes.

Authors:  Kai Chen; Dajiang Wu; Yushu Bai; Xiaodong Zhu; Ziqiang Chen; Chuanfeng Wang; Yingchuan Zhao; Ming Li
Journal:  Pathol Oncol Res       Date:  2013-11-30       Impact factor: 3.201

4.  Microfluidic fabrication of cell adhesive chitosan microtubes.

Authors:  Jonghyun Oh; Keekyoung Kim; Sung Wook Won; Chaenyung Cha; Akhilesh K Gaharwar; Seila Selimović; Hojae Bae; Kwang Ho Lee; Dong Hwan Lee; Sang-Hoon Lee; Ali Khademhosseini
Journal:  Biomed Microdevices       Date:  2013-06       Impact factor: 2.838

5.  Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease.

Authors:  Y Y Yuan; P J Kostenuik; M S Ominsky; S Morony; S Adamu; D T Simionescu; D M Basalyga; F J Asuncion; T A Bateman
Journal:  Osteoporos Int       Date:  2007-11-24       Impact factor: 4.507

6.  The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

Authors:  T L Burgess; Y Qian; S Kaufman; B D Ring; G Van; C Capparelli; M Kelley; H Hsu; W J Boyle; C R Dunstan; S Hu; D L Lacey
Journal:  J Cell Biol       Date:  1999-05-03       Impact factor: 10.539

7.  TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

Authors:  K Fuller; B Wong; S Fox; Y Choi; T J Chambers
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.